医療レポート：Hemophilia-疫学予測（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 Catalyst 6
3 Epidemiology 7
3.1 Disease Background 7
3.2 Risk Factors and Comorbidities 8
3.2.1 Almost 50% of Hemophilia Patients are Affected by Hypertension 9
3.3 Global Trends 9
3.4 Epidemiological Forecast of Hemophilia (2012-2022) 11
3.4.1 Forecast Methodology 11
3.4.2 Sources Used 13
3.4.3 Sources Not Used 14
3.4.4 Forecast Assumptions and Methods 14
3.5 Epidemiology Forecast (2012-2022), Hemophilia A 18
3.5.1 Diagnosed Prevalent Cases of Hemophilia A 18
3.5.2 Diagnosed Prevalent Cases of Hemophilia A by Age 20
3.5.3 Diagnosed Prevalent Cases of Hemophilia A by Sex 21
3.5.4 Age-Standardized Prevalence of Diagnosed Hemophilia A 23
3.6 Epidemiology Forecast (2012-2022), Hemophilia B 25
3.6.1 Diagnosed Prevalent Cases of Hemophilia B 25
3.6.2 Diagnosed Prevalent Cases of Hemophilia B by Age 26
3.6.3 Diagnosed Prevalent Cases of Hemophilia B by Sex 28
3.6.4 Age-Standardized Prevalence of Diagnosed Hemophilia B 30
3.7 Epidemiology Forecast (2012-2022), Hemophilia A and B 31
3.7.1 Diagnosed Prevalent Cases of Hemophilia A and B 31
3.7.2 Diagnosed Prevalent Cases of Hemophilia A and B by Sex 33
3.8 Discussion 35
3.8.1 Conclusions on Epidemiological Trends 35
3.8.2 Limitations of the Analysis 36
3.8.3 Strengths of the Analysis 37
4 Appendix 38
4.1 Bibliography 38
4.2 About the Authors 40
4.2.1 Epidemiologists 40
4.2.2 Reviewers 41
4.2.3 Global Director of Epidemiology and Health Policy 41
4.2.4 Global Head of Healthcare 42
4.3 About GlobalData 43
4.4 About EpiCast 43
4.5 Disclaimer 43